drugset / Trial / NCT02125162
A Study of the Relative Bioavailability of a New Formulation of BCX4161 and the Effect of Food on BCX4161
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of the study is to compare how the body takes up and then eliminates the study drug BCX4161 when it is taken orally as a hard gelatin capsule and as a soft gelatin capsule. This study will also evaluate whether food has any effect on how the body takes up BCX4161.
Timeline
- Start
- 2014-04
- Primary completion
- 2014-07
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | avoralstat | Small molecule | 400 mg | Oral |